Long-term Effectiveness of Occlusal Splint Therapy Compared to Placebo in Patients with Chronic Temporomandibular Disorders

Abstract

PurposeThe aim of this study was to compare long-term effectiveness of stabilization splint (SS) with that of placebo splint (PS) in chronic TMD patients and to investigate differences in treatment outcomes based on diagnostic subgroups [disc displacement (DD)/myofascial pain (MP)].Materials and MethodsThirty-four female participants, diagnosed with chronic TMD, were classified in groups: one provided with SS and other with PS and were followed for six months. Treatment outcomes included spontaneous pain [visual analogue scale (VAS)], self-perceived quality of life (OHIP-14), pain-free maximal mouth opening (MCO), maximal mouth opening (MMO), level of perceived stress (PSS), characteristic pain intensity [graded chronic pain scale (GCPS)], and functional jaw limitation [jaw functional limitation scale (JFLS)].ResultsBaseline characteristics did not differ significantly between the two groups (p>0.05). After six months of treatment the changes in spontaneous pain and OHIP-14 scores differed significantly between treatment groups (p=0.004, p=0.02 respectively), with greater reduction in SS compared to the PS group. Pain-free maximal mouth opening did not change significantly over time, however MCO values differed significantly between the two treatment groups, with greater overall values in the SS compared to the PS group (p= 0.046), as well as between TMD subgroups, with greater overall values in MP compared to DD patients (p= 0.03). In the SS group, significant difference in JFLS categories was found between baseline and after 6 months of treatment in all except emotional and verbal expression (mastication p=0.00015; vertical jaw mobility p=0.00018). No such changes in JFLS categories were observed in the PS group.ConclusionsDuring 6-month period, SS was more effective than PS in reducing spontaneous pain and improving self-perceived quality of life and functional limitations of the lower jaw. Moreover, significantely higher values of pain-free mouth opening were observed in patients treated with stabilization splint. While placebo might be partly responsible for improving the symptoms of TMD, it seems that itcannot maintain a continual long-term positive therapeutic effect.

The Influence of the COVID-19 Pandemic on the Stress Levels and Occurrence of Stomatoghnatic System Disorders (SSDs) among Physiotherapy Students in Poland

“…As a consequence, symptoms such as: bruxism, pain in the temporomandibular joints (TMJs), and headaches may appear. Long-term symptoms of SSDs may contribute to irreversible changes in this system, resulting in impaired chewing, swallowing, speech, and breathing functions [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. Additionally, long-term reports about TMJ internal derangements were released [21][22][23][24][25].…”

“…In medical terms, it is defined as a disorder of the body's homeostasis caused by physical or psychological elements [6][7][8]. It can be caused by mental, physiological, anatomical [7,8], or physical factors [9][10][11]14]. Stressful situations lead to increased muscle tension, which is the body's natural response to threat.…”

Treatment of temporomandibular dysfunction with jaw functional orthopedics: a retrospective study

“…Yatani et al [19] and Vrbanovic & Alajbeg [66] reported long-term stability of TMD treatment using occlusal splints. This type of data was not found in the literature for the results of JFO, showing the need for research about the stability of JFO results.…”

Analysis of splint weaning in temporomandibular disorder patients

“…5 One study found that relative to a placebo group, a group treated with splint could more easily open the mouth without pain and showed a practical treatment effect after 6 months. 20 However, some side effects can occur including occlusal changes, dental/myofascial discomfort, TMJ pain, xerostomia, and excess salivation. The occlusal changes can be significant.…”